125 related articles for article (PubMed ID: 1330432)
1. Exemplary data: sample size and power in the design of event-time clinical trials.
Goldman AI; Hillman DW
Control Clin Trials; 1992 Aug; 13(4):256-71. PubMed ID: 1330432
[TBL] [Abstract][Full Text] [Related]
2. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
Royston P; Parmar MK
BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the statistical power for multiple tests: a case study.
Yeo A; Qu Y
Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
5. Optimization of adaptive designs: efficiency evaluation.
Menon S; Chang M
J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
[TBL] [Abstract][Full Text] [Related]
6. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
Kombrink K; Munk A; Friede T
Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
[TBL] [Abstract][Full Text] [Related]
7. A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints.
Natarajan R; Turnbull BW; Slate EH; Clark LC
Comput Methods Programs Biomed; 1996 Mar; 49(2):137-47. PubMed ID: 8735021
[TBL] [Abstract][Full Text] [Related]
8. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
9. Robust inference for group sequential trials.
Ganju J; Lin Y; Zhou K
Pharm Stat; 2017 Mar; 16(2):167-173. PubMed ID: 28133895
[TBL] [Abstract][Full Text] [Related]
10. A note on P-values under group sequential testing and nonproportional hazards.
Gillen DL; Emerson SS
Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
[TBL] [Abstract][Full Text] [Related]
11. Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
Sugimoto T; Hamasaki T; Evans SR; Halabi S
Lifetime Data Anal; 2020 Apr; 26(2):266-291. PubMed ID: 30980317
[TBL] [Abstract][Full Text] [Related]
12. Gumbel based p-value approximations for spatial scan statistics.
Abrams AM; Kleinman K; Kulldorff M
Int J Health Geogr; 2010 Dec; 9():61. PubMed ID: 21167043
[TBL] [Abstract][Full Text] [Related]
13. Sample size and the probability of a successful trial.
Chuang-Stein C
Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
[TBL] [Abstract][Full Text] [Related]
14. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
15. Sample size computations for PK/PD population models.
Kang D; Schwartz JB; Verotta D
J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):685-701. PubMed ID: 16284914
[TBL] [Abstract][Full Text] [Related]
16. Weibull prediction of event times in clinical trials.
Ying GS; Heitjan DF
Pharm Stat; 2008; 7(2):107-20. PubMed ID: 17377932
[TBL] [Abstract][Full Text] [Related]
17. Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors.
Larsen MS; Juul RV; Kreilgaard M; Kristensen AT; Simonsson USH
Eur J Pharm Sci; 2018 Oct; 123():531-538. PubMed ID: 30077714
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.
Chen YF; Yang Y; Hung HM; Wang SJ
Contemp Clin Trials; 2011 Jul; 32(4):592-604. PubMed ID: 21540126
[TBL] [Abstract][Full Text] [Related]
19. An asymptotic test for the equality of coefficients of variation from k populations.
Feltz CJ; Miller GE
Stat Med; 1996 Mar; 15(6):646-58. PubMed ID: 8731006
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Levin GP; Emerson SC; Emerson SS
Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
